Nicole E. Chong

From β-Blasts to α-Bombs: Bone-Targeting Radiopharmaceutical Therapies.

Bone metastases are a significant source of morbidity in advanced malignancy, particularly in prostate cancer, because osteoblastic metastases can cause pain, skeletal-related events, and quality-of-life impairment. Bone-targeting radionuclide drugs are also effective in the treatment of increased bone turnover and wer...